Recombinant Human KAT2A Protein，His

KAT2A, or Lysine Acetyltransferase 2A, is a crucial enzyme involved in the regulation of gene expression through histone acetylation, a post-translational modification that alters chromatin structure and subsequently influences transcriptional activity. This enzyme plays a vital role in various cellular processes, including cell differentiation, proliferation, and metabolism. Dysregulation of KAT2A has been implicated in several diseases, including cancer, where it may contribute to the aberrant expression of oncogenes and tumor suppressors. As research on epigenetics gains momentum, KAT2A has emerged as a potential target for therapeutic interventions aimed at reversing abnormal gene expression patterns observed in various pathologies. The study of recombinant KAT2A protein allows for a deeper understanding of its enzymatic mechanisms, substrate specificity, and interactions with other proteins within the context of the acetylation cycle. This research not only enhances the fundamental knowledge of KAT2A's function but also paves the way for the development of small-molecule inhibitors or activators that could be harnessed for clinical applications. Understanding KAT2A's role in health and disease could lead to innovative strategies for targeted therapies in cancer and other disorders related to epigenetic modifications.